These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Yeh MK J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421 [TBL] [Abstract][Full Text] [Related]
6. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679 [TBL] [Abstract][Full Text] [Related]
7. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. Coombes AG; Yeh MK; Lavelle EC; Davis SS J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451 [TBL] [Abstract][Full Text] [Related]
8. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Yeh MK; Davis SS; Coombes AG Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of gentamicin released from microparticles. Blanco-Príeto MJ; Lecaroz C; Renedo MJ; Kunkova J; Gamazo C Int J Pharm; 2002 Aug; 242(1-2):203-6. PubMed ID: 12176247 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of surface-indented protein-loaded PLGA microparticle formation: the effects of salt (NaCl) on the solidification process. Chen JL; Yeh MK; Chiang CH J Microencapsul; 2004 Dec; 21(8):877-88. PubMed ID: 15799543 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Bittner B; Morlock M; Koll H; Winter G; Kissel T Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634 [TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro characteristics for insulin-loaded PLA microparticles prepared by w/o/w solvent evaporation method with electrolytes in the continuous phase. Yeh MK; Chen JL; Chiang CH J Microencapsul; 2004 Nov; 21(7):719-28. PubMed ID: 15799222 [TBL] [Abstract][Full Text] [Related]
13. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
14. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296 [TBL] [Abstract][Full Text] [Related]
15. Optimization of preparative conditions for poly-DL-lactide- polyethylene glycol microspheres with entrapped Vibrio cholera antigens. Deng XM; Li XH; Yuan ML; Xiong CD; Huang ZT; Jia WX; Zhang YH J Control Release; 1999 Mar; 58(2):123-31. PubMed ID: 10053185 [TBL] [Abstract][Full Text] [Related]